Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Commun Biol. 2024 Aug 21;7(1):1030. doi: 10.1038/s42003-024-06722-4.
ABSTRACT
Alcoholic liver disease (ALD) is a disease with high incidence, limited therapies, and poor prognosis. The present study aims to investigate the effect of riboflavin on ALD and explore its potential therapeutic mechanisms. C57BL/6 mice were divided into the control, alcohol, and alcohol+ riboflavin groups. 16S rRNA-seq and RNA-seq analysis were utilized to analyze the polymorphism of intestinal microbiota and the transcriptome heterogeneity respectively. KEGG and GO enrichment analysis were performed. CIBERSORTx was applied to evaluate the immune cell infiltration level. Publicly available transcriptome data of ALD was enrolled and combined with the RNA-seq data to identify the immune subtypes of ALD. Pathological and histology analysis demonstrated that riboflavin reversed the progression of ALD. 16S rRNA-seq results showed that riboflavin could regulate alcohol-induced intestinal microbiota alteration. Intestinal microbiota polymorphism analysis indicated that VLIDP may contribute to the progression of ALD. Based on the VLIDP pathway, two subtypes were identified. Immune microenvironment analysis indicated that the upregulated inflammatory factors may be important regulators of ALD. In conclusion, intestinal microbiota homeostasis was associated with the protective effect of riboflavin against ALD, which was likely mediated by modulating inflammatory cell infiltration. Riboflavin emerges as a promising therapeutic candidate for the management of ALD.
PMID:39169207 | DOI:10.1038/s42003-024-06722-4
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Lacticaseibacillus rhamnosus LRa05 alleviated liver injury in mice with alcoholic fatty liver disease by improving intestinal permeability and balancing gut microbiota Apolipoprotein H deficiency exacerbates alcohol-induced liver injury via gut Dysbiosis and altered bile acid metabolism The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics Water decoction of Pericarpium citri reticulatae and Amomi fructus ameliorates alcohol-induced liver disease involved in the modulation of gut microbiota and TLR4/NF-κB pathway The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification IFN-β Overexpressing Adipose-Derived Mesenchymal Stem Cells Mitigate Alcohol-Induced Liver Damage and Gut Permeability An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-kappaB/MLKL pathway Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Solanum nigrum L. berries extract ameliorated the alcoholic liver injury by regulating gut microbiota, lipid metabolism, inflammation, and oxidative stress Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement A comprehensive investigation of dietary micronutrients intakes and the risk of alcoholic liver disease Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder The alleviative effects of viable and inactive Lactobacillus paracasei CCFM1120 against alcoholic liver disease via modulation of gut microbiota and the Nrf2/HO-1 and TLR4/MyD88/NF-kappaB pathways Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD A protective mechanism of heat inactivation to enhance Levilactobacillus brevis PDD-2 against alcohol-induced chronic liver disease based on proteomic analysis No causal relationship between serum vitamin D levels and alcoholic liver disease: a two-sample bidirectional Mendelian randomization study Alcohol-associated liver disease and public health policies Oxidative stress in alcoholic liver disease, focusing on proteins, nucleic acids, and lipids: A review Cyanidin-3-O-glucoside alleviates ethanol-induced liver injury by promoting mitophagy in a Gao-binge mouse model of alcohol-associated liver disease Alcoholic Liver Disease/Non-Alcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease Development of an alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell-derived liver organoids Development of an alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell-derived liver organoids New nomenclature for fatty liver disease Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review Maslinic acid alleviates alcoholic liver injury in mice and regulates intestinal microbiota via the gut-liver axis Alcoholic Liver Disease in China: A Disease Influenced by Complex Social Factors That Should Not Be Neglected Hericium erinaceus polysaccharides ameliorate nonalcoholic fatty liver disease via gut microbiota and tryptophan metabolism regulation in an aged laying hen model The protective effects of aqueous extract of Schisandra sphenanthera against alcoholic liver disease partly through the PI3K-AKT-IKK signaling pathway Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology Musculus senhousei peptides alleviated alcoholic liver injury via the gut-liver axis When Should Patients With Less Than 6 Months Sobriety Be Transplanted? Multi-omics analysis of the biological mechanism of the pathogenesis of non-alcoholic fatty liver disease Efficacy of Rhamnus utilis Decne. Aqueous extract in mice with acute alcoholic liver injury and metabolomic study Efficacy of Rhamnus utilis Decne. Aqueous extract in mice with acute alcoholic liver injury and metabolomic study Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy Hepatoprotective potential of four fruit extracts rich in different structural flavonoids against alcohol-induced liver injury via gut microbiota-liver axis Aronia Melanocarpa Elliot Anthocyanins Inhibits Alcoholic Liver Disease by Activation of alpha7nAChR Aronia Melanocarpa Elliot Anthocyanins Inhibits Alcoholic Liver Disease by Activation of alpha7nAChR Diagnostic role of SPP1 and collagen IV in a rat model of type 2 diabetes mellitus with MASLD Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact The roles and potential mechanisms of plant polysaccharides in liver diseases: a review Serum miR‑29 is increased in mice with early liver fibrosis Effects of Marine Natural Products on Liver Diseases Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease Nobiletin Protects Against Alcoholic Liver Disease in Mice via the BMAL1-AKT-Lipogenesis Pathway The role and mechanism of SUMO modification in liver disease Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice
Evidence Blueprint
Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Intestinal microbiota homeostasis analysis in riboflavin-treated alcoholic liver disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Lacticaseibacillus rhamnosus LRa05 alleviated liver injury in mice with alcoholic fatty liver disease by improving intestinal permeability and balancing gut microbiota Fucoidan from Apostichopus japonicus ameliorates alcoholic liver disease by regulating gut-liver axis homeostasis Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice The protective effect of Nostoc commune Vauch. polysaccharide on alcohol-induced acute alcoholic liver disease and gut microbiota disturbance in mice Apolipoprotein H deficiency exacerbates alcohol-induced liver injury via gut Dysbiosis and altered bile acid metabolism The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics Protection of Inonotus hispidus (Bull.) P. Karst. against Chronic Alcohol-Induced Liver Injury in Mice via Its Relieving Inflammation Response Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease Water decoction of Pericarpium citri reticulatae and Amomi fructus ameliorates alcohol-induced liver disease involved in the modulation of gut microbiota and TLR4/NF-κB pathway The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets Symbiotic combination of Akkermansia muciniphila and inosine alleviates alcohol-induced liver injury by modulating gut dysbiosis and immune responses Kupffer cell diversity maintains liver function in alcohol-associated liver disease Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation Regulation of intestinal microflora and metabolites of Penthorum chinense Pursh on alcoholic liver disease Roles of Gut Microbiota in Alcoholic Liver Disease The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification IFN-β Overexpressing Adipose-Derived Mesenchymal Stem Cells Mitigate Alcohol-Induced Liver Damage and Gut Permeability Lactobacillus plantarum ST-III culture supernatant protects against acute alcohol-induced liver and intestinal injury Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease 1H NMR Serum Metabolomic Change of Trimethylamine N-oxide (TMAO) Is Associated with Alcoholic Liver Disease Progression An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-kappaB/MLKL pathway Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation Exploring the Potential Role of Massa Medicata Fermentata in Alcoholic Liver Injury Disease Based on Network Pharmacology and Animal Experiments Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study Solanum nigrum L. berries extract ameliorated the alcoholic liver injury by regulating gut microbiota, lipid metabolism, inflammation, and oxidative stress Structural elucidation of a highly branched α-D-glucan from Huangjiu and its hepatoprotective activity via gut microbiome regulation and intestinal barrier repairment Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement A comprehensive investigation of dietary micronutrients intakes and the risk of alcoholic liver disease Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress Antibiotics attenuate diet-induced non-alcoholic fatty liver disease without altering intestinal barrier dysfunction Integrated Multidisciplinary Management of Alcohol-associated Liver Disease Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder Pomegranate-Derived Exosome-Like Nanovesicles Alleviate Binge Alcohol-Induced Leaky Gut and Liver Injury From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients Promoting intestinal antimicrobial defense and microbiome symbiosis contributes to IL-22-mediated protection against alcoholic hepatitis in mice Network medicine-based analysis of the hepatoprotective effects of Amomum villosum Lour. on alcoholic liver disease in rats Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease The alleviative effects of viable and inactive Lactobacillus paracasei CCFM1120 against alcoholic liver disease via modulation of gut microbiota and the Nrf2/HO-1 and TLR4/MyD88/NF-kappaB pathways ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease Astaxanthin Protects against Alcoholic Liver Injury via Regulating Mitochondrial Redox Balance and Calcium Homeostasis Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease